Unlock instant, AI-driven research and patent intelligence for your innovation.

Reagent and method for detecting leucocythemia susceptibility

A kit and susceptibility technology, applied to the kit for detecting leukemia susceptibility, in the field of detecting leukemia susceptibility, can solve the problem of expression decline

Inactive Publication Date: 2007-03-21
PEKING UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the National Human Genome South Research Center used DNA chip technology to study differentially expressed genes in liver cancer and found that the expression of some apoptosis-related genes such as PDCD5, PDCD8, Bak, TRAF6 and TRAIL was significantly decreased in liver cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Reagent and method for detecting leucocythemia susceptibility
  • Reagent and method for detecting leucocythemia susceptibility
  • Reagent and method for detecting leucocythemia susceptibility

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The acquisition of embodiment 1.SNP

[0030] Step 1: Extraction of Genomic DNA

[0031] Using a small amount of peripheral blood leukocyte genomic DNA rapid extraction and purification kit (Shanghai Huashun Bioengineering Co., Ltd.), 2ml of human whole blood was used to extract genomic DNA; after the concentration was corrected to 50ng / μl, it was used for conventional PCR amplification.

[0032] Step 2: SNP acquisition

[0033] Perform specific PCR amplification on the genomic DNA extracted in step 1, perform direct sequencing after purification of the amplified products, and compare the sequences of the PCR amplification products determined to obtain sequence differences and obtain SNPs. Wherein, the PCR reaction condition is 95° C. for 3 minutes, 35 cycles of 95° C. for 30 seconds, 68° C. for 1 minute, and finally 72° C. for 7 minutes. Primers are:

[0034] Sense primer: 5'-CGGGGAATCGGGCCTCTGC-3' (SEQ ID NO: 2)

[0035] Antisense primer: 5'-CAAGCTCCTCGTCCGCCATG-3'...

Embodiment 2

[0037] Embodiment 2. Detection kit

[0038] Step 1: Extraction of DNA template

[0039] 2 ml of human peripheral blood was extracted by conventional methods, and genomic DNA in these blood samples was extracted by conventional methods.

[0040] Step 2: PCR reaction

[0041] Prepare a detection kit for detecting the susceptibility of PDCD5 gene-related diseases, which contains the following primer pairs that can amplify the 154-position and 170-position SNP:

[0042] Sense primer: 5'-GCTCCGGGCTGGATTGGTG-3' (SEQ ID NO: 6)

[0043] Antisense primer: 5'-CATGGCTCGGCGTCAGCG-3' (SEQ ID NO: 12)

[0044] The PCR reaction conditions were 95° C. for 3 minutes, 35 cycles of 95° C. for 30 seconds, 68° C. for 1 minute, and finally 72° C. for 7 minutes.

[0045] Step 3: Gene Analysis

[0046] Genotype analysis was carried out on the amplified product by RFLP technology. Since the 170th G polymorphism produced a Nar I endonuclease site and the 154th A destroyed a Nar I restriction site, ...

Embodiment 3

[0047] Example 3. Functional effect analysis of 154A>G / 170G>A polymorphism in the PDCD5 promoter region Step 1, Construction of 154G / 170A genotype and 154A / 170G genotype promoter region reporter vector

[0048] A 743bp DNA fragment from position 643 upstream of the transcription start site to position 91 downstream of the transcription start site in the PDCD5 promoter region containing the 154G / 170A mutant genotype and the 154A / 170G wild genotype was cloned into pGL3-Basic ( Promega Company) reporter plasmid, the luciferase reporter gene plasmid pGL3-PDCD5-170A (154G / 170A) containing 154G / 170A mutant type and the pGL3-PDCD5-170G (154A / 170G) containing 154A / 170G wild type were constructed. Luciferase reporter gene plasmid.

[0049] Step 2. Detection of 154G / 170A genotype and 154A / 170G genotype promoter activity Transfect negative control pGL3-Basic, positive control pGL3-SV40 (Promega), pGL3-PDCD5-170A and pGL3-PDCD5-170G respectively In HEK293 cells, the cells were collected ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a agent box to testing leucocyte susceptibility that includes two SNPs specificity primer in the 154th and the 170th of the upstream 5' adjust region SEQ ID NO: 1 that is testing PDCD5 gene, and restrain inscribe enzyme that is testing the SNPs site. The invention predicts the susceptibility of leucocyte by testing the site of SNP.

Description

technical field [0001] The present invention relates to a kit for disease detection, especially a kit for detecting leukemia susceptibility, by detecting two functional single nucleotide polymorphisms in complete linkage disequilibrium ( SNP) loci to predict the susceptibility of an individual to leukemia, and further relate to a method for detecting susceptibility to leukemia. Background technique [0002] Programmed cell death (programmed cell death) is a physiological process of cell self-destruction, which plays a very important role in embryonic development, the stability of the organism's internal environment, and the defense of multicellular organisms from external and internal damage. The disorder of the apoptosis process may be directly or indirectly related to the occurrence of many diseases, such as tumors, autoimmune diseases, neurodegeneration such as Alzheimer's disease and local damage. The study of molecules related to programmed cell death has important the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68
Inventor 赵红珊马曦阮国瑞马大龙王莹李启艳朱平
Owner PEKING UNIV